Massachusetts Financial Services
MRVI icon

Massachusetts Financial Services’s Maravai LifeSciences MRVI Stock Holding History

Massachusetts Financial Services’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,079
Closed -$57.6K – 936
2025
Q3 		$57.6K Buy
20,079
+3,157
+19% +$8.06K ﹤0.01% 857
2025
Q2 		$40.8K Sell
16,922
-230,899
-93% -$485K ﹤0.01% 884
2025
Q1 		$548K Sell
247,821
-4,416,389
-95% -$17.5M ﹤0.01% 844
2024
Q4 		$25.4M Buy
4,664,210
+1,062,485
+29% +$6.84M 0.01% 573
2024
Q3 		$29.9M Sell
3,601,725
-948,778
-21% -$8.2M 0.01% 539
2024
Q2 		$32.6M Buy
4,550,503
+598,530
+15% +$5.17M 0.01% 524
2024
Q1 		$34.3M Sell
3,951,973
-2,062,602
-34% -$14M 0.01% 515
2023
Q4 		$39.4M Sell
6,014,575
-2,138,905
-26% -$13.8M 0.01% 489
2023
Q3 		$81.5M Sell
8,153,480
-3,000,776
-27% -$33M 0.03% 381
2023
Q2 		$139M Sell
11,154,256
-603,231
-5% -$8.14M 0.05% 311
2023
Q1 		$165M Sell
11,757,487
-1,290,473
-10% -$18.5M 0.06% 270
2022
Q4 		$187M Sell
13,047,960
-1,102,931
-8% -$17.4M 0.07% 247
2022
Q3 		$361M Buy
14,150,891
+1,459,720
+12% +$36.6M 0.14% 168
2022
Q2 		$361M Buy
12,691,171
+3,726,068
+42% +$118M 0.12% 172
2022
Q1 		$316M Buy
8,965,103
+962,082
+12% +$32.3M 0.09% 196
2021
Q4 		$335M Buy
8,003,021
+2,459,692
+44% +$99.6M 0.09% 194
2021
Q3 		$272M Buy
5,543,329
+523,916
+10% +$25.6M 0.08% 213
2021
Q2 		$209M Sell
5,019,413
-363,705
-7% -$14.1M 0.06% 255
2021
Q1 		$192M Buy
5,383,118
+1,146,511
+27% +$38M 0.06% 267
2020
Q4 		$119M Buy
+4,236,607
New +$118M 0.04% 338

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services's MRVI Position: Q4 2025 in Review

Massachusetts Financial Services sold out of Maravai LifeSciences (MRVI) in Q4 2025, closing a stake of 20,079 shares — an estimated $57.6K sold.

Massachusetts Financial Services first reported a position in MRVI in Q4 2020 and held it in 20 quarters. The position peaked at $361M in Q3 2022. 159 funds tracked by Wall St. Rank hold MRVI as of Q4 2025.

  • Massachusetts Financial Services reported no remaining Maravai LifeSciences position as of Q4 2025 after selling out during the quarter.
  • Massachusetts Financial Services sold 20,079 Maravai LifeSciences shares in Q4 2025, an estimated $57.6K.
  • Massachusetts Financial Services first reported a position in Maravai LifeSciences in Q4 2020 and held it in 20 quarters.
  • Massachusetts Financial Services's Maravai LifeSciences position peaked at $361M in Q3 2022.
  • 159 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2025.

Based on Massachusetts Financial Services's 13F filing for Q4 2025, filed 22 Jan 2026.